Aesthetics is no longer moving in a straight line. It is expanding, colliding, and evolving into something much bigger than beauty alone.
This is no longer about choosing a treatment and hoping it works. The industry is moving toward a model where outcomes can be anticipated, care is tailored to the individual, and aesthetics, wellness, and longevity are starting to operate as one connected system.
In this episode of The Dr. Randi Show, Dr. Randi sits down with Anthony Serhan, founder and CEO of Pink Sky and a longtime industry insider with more than two decades across pharma, aesthetics, and device innovation, including executive leadership at Merz Aesthetics.
From what he’s seeing across the market, this is not incremental change. It’s a rethinking of how patients are treated, how clinics operate, and how results are delivered.
Dr. Randi and Anthony break down:
• The rise of peptides, regenerative treatments, and GLP-1s and how they are changing patient expectations
• How genetic and biomarker testing will predict which treatments work for you before you spend the time or money
• What exosomes, NAD, and hair restoration signal about where real demand is heading
• The emergence of next-level therapies designed to reset and recharge the body, from advanced blood treatments to oxygen-based performance therapies
• Why treatment stacking is becoming the new standard for delivering impactful results
This is a clear look at where the industry is going from someone who has helped build it and knows what’s coming next.
Sponsored by NewBeauty 💄
📱 Listen and Watch on Spotify: https://spti.fi/d19M3to
🎧 Listen Now on Apple: https://dub.link/3vD2xhj
